Latest Malaria prophylaxis Stories
Researchers have identified a potential new weapon and approach for attacking the parasites that cause malaria.
The world should aim to have vaccines which reduce malaria cases by 75 percent, and are capable of eliminating malaria, licensed by 2030, according to the updated 2013 Malaria Vaccine Technology Roadmap, launched today.
Medicines for Malaria Venture has developed a framework to evaluate the risk of resistance for the antimalarial compounds in its portfolio.
Researchers have discovered a group of chemical compounds that might one day be developed into drugs that can treat malaria infection in both the liver and the bloodstream.
For some time now, artemisinin, derived from a Chinese herb, has been the most powerful treatment available against malaria.
Researchers at the University of South Florida (USF) College of Public College Health have shown for the first time in a rodent model that the earliest form of malaria parasites can lay dormant in red blood cells and “wake up,” or recover, following treatment with the antimalarial drug artesunate.
The first evidence of resistance to the world's most effective drug for treating malaria has been found by international scientists.
The afflictions of impoverished Cambodia can be seen in the nationâ€™s western corner: girls for hire standing outside restaurants, uneven dirt roads dotted with signs that warn â€œDanger Mines!â€